China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
1970-01-01 08:00
A Doctor With Brain Cancer Is Helping Transform Its Treatment
When Richard Scolyer was diagnosed with a deadly brain tumor in June, he grasped the test results as
1970-01-01 08:00
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
1970-01-01 08:00
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
1970-01-01 08:00
Pfizer Misses Quarterly Sales Estimates, Lowering Outlook
Pfizer Inc. missed revenue estimates for the second quarter as sales of its Covid pill fell drastically short
1970-01-01 08:00
Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut
When Exondys 51 was approved to treat Duchenne muscular dystrophy, a deadly disease that puts kids in wheelchairs
1970-01-01 08:00